| 1 |
What type of learning is discussed in relation to newborn infants in the context of sound sequences?
|
Statistical learning |
|
I chose “Statistical Learning” because the article highlights newborns’ ability to detect patterns in sound sequences.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
What experimental method was used to study the infants?
|
EEG experiments |
|
I chose “EEG Experiments” because the article mentions using EEG to study infants’ brain responses to sounds.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What was used to induce a beat in sound sequences during the study?
|
Isochronous timing |
|
|
Enables listeners to readily recognize and synchronize with a regular pulse, which is the fundamental characteristic of a beat.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What is a key outcome of beat perception studies in newborns?
|
Indifference to rhythmic patterns |
|
Newborns can detect and respond to rhythmic patterns, suggesting beat perception is innate. EEG studies show neural entrainment to rhythms, highlighting an early sensitivity to temporal structures in sound.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What does the mismatch response (MMR) indicate in newborn infants?
|
Regularity violation detection |
|
MMR shows that newborns detect deviations in sound patterns, indicating early recognition of regularities and violations in auditory input.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What aspect of the sound was manipulated to test beat perception separately from statistical learning?
|
Timing (isochronous vs. jittered) |
|
Timing (Isochronous vs. Jittered) isolates beat perception by maintaining or disrupting a regular pulse, separating it from statistical learning.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the study, why is the detection of a beat significant in newborns?
|
|
|
I chose “It Indicates A Foundational Musical Trait” because beat detection in newborns shows that rhythm perception is an innate, fundamental aspect of musical cognition.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
How does the article describe the relationship between statistical learning and beat processing in newborns?
|
Statistically learning leads to beat processing |
|
I chose “Statistically Learning Leads To Beat Processing” because statistical learning helps infants detect patterns, supporting their ability to process beats.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which physiological measure was primarily used to assess responses to sound sequences in the study?
|
Electroencephalography (EEG) |
|
I chose EEG because it measures brain activity and is commonly used to assess responses to sound sequences in infants.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What does the presence of a clear Mismatch Response (MMR) to beat and offbeat positions in an isochronous condition suggest about newborns' auditory capabilities?
|
Advanced capabilities in detecting rhythm |
|
I chose “Advanced Capabilities in Detecting Rhythm” because the MMR response to beat and offbeat positions suggests that newborns can detect rhythmic patterns and deviations, showing early sensitivity to rhythm, but hey who knows im just saying.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the main focus of the cell and gene therapies article?
|
Evidence-based cell and gene therapies |
|
I chose “Evidence-Based Cell and Gene Therapies” because it matches the topic, while the other options are obviously unrelated.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
What does CGT stand for in the context of the article?
|
Cell and Gene Therapies |
|
I chose “Cell and Gene Therapies” because CGT is commonly used for this in medical contexts.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What does the article caution against?
|
Direct-to-consumer marketing of unproven CGTs |
|
I chose “Direct-To-Consumer Marketing of Unproven CGTs” because the article warns about selling unproven therapies to consumers.
|
Common sense mostly.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
According to the article, what is a risk associated with unproven CGTs?
|
Misleading advertising |
|
I chose “Misleading Advertising” because the article highlights the risk of deceptive claims about unproven CGTs.
|
I mean it’s the only thing that’s connected with the topic about unproven CGTs.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which platform is mentioned for registering research that might not be credible?
|
ClinicalTrials.gov |
|
I chose “ClinicalTrials.gov” because the article mentions concerns about unverified research on this platform.
|
I did some research about all the websites in the choices above.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
What term is used to describe items that make unproven CGTs appear valid?
|
Tokens of Legitimacy |
|
I chose “Tokens of Legitimacy” because the article uses it to describe things that falsely boost CGTs’ credibility.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What does the ISCT oppose according to the article?
|
Premature commercialization of unproven CGTs |
|
I chose “Premature Commercialization of Unproven CGTs” because the ISCT opposes rushing unproven therapies to market before proper validation. 
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
Which regulatory body is NOT mentioned in the article as a key player in CGT oversight?
|
CDC |
|
I chose “CDC” because the article mentions the FDA, EMA, Health Canada, and WHO, but not the CDC.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What specific role do 'tokens of legitimacy' play according to the article?
|
Persuade patients of the safety and efficacy of unproven CGTs |
|
I chose “Persuade Patients of the Safety and Efficacy of Unproven CGTs” because ‘tokens of legitimacy’ mislead patients about unproven therapies.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
According to the article, what is a critical measure for distinguishing evidence-based CGTs?
|
Pre-marketing authorization by national regulatory bodies |
|
I chose “Pre-Marketing Authorization By National Regulatory Bodies” because the article highlights the importance of regulatory approval for evidence-based CGTs.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|